Navigation Links
Dr Reddy’s Laboratories launches Hyalosy

The Hyderabad-based Dr Reddy’s Laboratories has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that provides relief from knee-joint stiffness and immobility among patients suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent disease. More than 90 per cent of people above the age of 45 are estimated to show signs of this disease, and it is the leading cause of disability in people above the age of 65. //

Hyaluronic acid, the active substance in Hyalosyn, a naturally occurring substance found in Synovial fluid, surrounds the joints. Hyaluronic acid acts as a lubricant that enables bones to move smoothly over each other and also acts as a shock absorber for joints. Hyalosyn is an emerging therapy for osteoarthritis. Hyalosyn will provide the much-needed relief to patients suffering from severe osteoarthritis and will enable them to resume their daily activities.

Hyalosyn will be marketed as a sterile, pre-filled syringe containing 20 mg/2ml of sodium hyaluronate. Hyalosyn is being launched under a co-marketing arrangement with Gland Pharma, a pharmaceutical company in Hyderabad well known for the production of pre-filled injectables. The introduction of Hyalosyn would further strengthen the company’s arthritis franchise in which it is already a leading player in the domestic market.
'"/>




Page: 1

Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. Dr Reddy’s Laboratories to challenge patents on drug
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
6. Abbott’s Laboratories R&D Capabilities Questione
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. ICMR to Set up Laboratories to Combat Bird Flu
9. Ranbaxy Laboratories to Be Aided in Drug Research
10. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
11. Glaxo launches pills to help smokers quit in 7-12 weeks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... ... and human performance, is proud to announce that it has received 510(k) clearance ... technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring ... birth defects research related to Zika virus during pregnancy, as well as other ... this important science. , The Teratology Society is an international ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
(Date:4/19/2017)... research provides evidence that an old drug may provide relief ... today that will be presented at the American Academy ... , April 22 to 28, 2017. ... oral drug levodopa has long been considered the gold standard, ... progresses, the effects of the medication can partially wear off ...
Breaking Medicine Technology: